Literature DB >> 9356017

Impaired beta-cell function and deposition of fat droplets in the pancreas as a consequence of hypertriglyceridemia in OLETF rat, a model of spontaneous NIDDM.

Z W Man1, M Zhu, Y Noma, K Toide, T Sato, Y Asahi, T Hirashima, S Mori, K Kawano, A Mizuno, T Sano, K Shima.   

Abstract

Hypertriglyceridemia is known to be a feature of obesity-related NIDDM, but the patho-etiological significance of this association is obscure. The effects of triglycerides (TGs) on beta-cell function and morphological changes in pancreas were examined using in vivo and in vitro approaches in male OLETF rats at ages 6, 12, and 30 weeks, with their diabetes-resistant counterpart, LETO rats, as normal controls. The results showed that, in the fasting state, plasma TGs in OLETF rats were increased 2.5-fold at age 6 weeks, 3.3-fold at age 12 weeks, and 6.2-fold at age 30 weeks, compared with age-matched LETO rats. The TG content in islets from 12-week-old OLETF rats was significantly increased when compared with those from their age-matched counterparts, but this was not the case with the 6-week-old OLETF rats. Therefore, the islets from 6-week-old rats were cultured with either free fatty acids (FFAs; 1.0 mmol/l sodium oleate) or TG (5.0 mmol/l Intralipide) for 72 h. Several abnormalities in OLETF rats were evident, in contrast to the results from control LETO rats: 1) glucose-induced insulin secretion was more inhibited by either FFAs or TGs in the presence of 27.7 mmol/l glucose, a result associated, at least in part, with reduced glucokinase activity in the islets; 2) a marked elevation in TG content was found in the islets; and 3) the deposition of fat droplets in the enlarged islets, even in the beta-cells, was found by Oil Red O-insulin double staining at age 30 weeks. In conclusion, hypertriglyceridemia resulted in significant TG stores in the islets, which subsequently inhibited glucose-induced insulin secretion, at least in part, via reduced glucokinase activity in the islets. Fat droplets in islets, therefore, may play an important role in hastening the development of NIDDM in this rat model.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9356017     DOI: 10.2337/diab.46.11.1718

Source DB:  PubMed          Journal:  Diabetes        ISSN: 0012-1797            Impact factor:   9.461


  10 in total

1.  Quantification of lipid droplets and associated proteins in cellular models of obesity via high-content/high-throughput microscopy and automated image analysis.

Authors:  Patrick M McDonough; Ramses M Agustin; Randall S Ingermanson; Patricia A Loy; Benjamin M Buehrer; James B Nicoll; Natalie L Prigozhina; Ivana Mikic; Jeffrey H Price
Journal:  Assay Drug Dev Technol       Date:  2009-10       Impact factor: 1.738

2.  Endocytosis of low-density lipoprotein by human pancreatic beta cells and uptake in lipid-storing vesicles, which increase with age.

Authors:  M Cnop; A Grupping; A Hoorens; L Bouwens; M Pipeleers-Marichal; D Pipeleers
Journal:  Am J Pathol       Date:  2000-01       Impact factor: 4.307

Review 3.  Metabolic implications of pancreatic fat accumulation.

Authors:  Robert Wagner; Sabine S Eckstein; Hajime Yamazaki; Felicia Gerst; Jürgen Machann; Benjamin Assad Jaghutriz; Annette Schürmann; Michele Solimena; Stephan Singer; Alfred Königsrainer; Andreas L Birkenfeld; Hans-Ulrich Häring; Andreas Fritsche; Susanne Ullrich; Martin Heni
Journal:  Nat Rev Endocrinol       Date:  2021-10-20       Impact factor: 43.330

4.  Lipid infusion lowers sympathetic nervous activity and leads to increased beta-cell responsiveness to glucose.

Authors:  C Magnan; S Collins; M F Berthault; N Kassis; M Vincent; M Gilbert; L Pénicaud; A Ktorza; F Assimacopoulos-Jeannet
Journal:  J Clin Invest       Date:  1999-02       Impact factor: 14.808

5.  Relationship between blood lipid profiles and pancreatic islet β cell function in Chinese men and women with normal glucose tolerance: a cross-sectional study.

Authors:  Tianpeng Zheng; Yun Gao; Haoming Tian
Journal:  BMC Public Health       Date:  2012-08-10       Impact factor: 3.295

6.  Morphological changes of parotid gland in experimental hyperlipidemia.

Authors:  Ioanna D Daskala; Christina C Tesseromatis
Journal:  Int J Dent       Date:  2011-03-21

Review 7.  Early Treatment with Basal Insulin Glargine in People with Type 2 Diabetes: Lessons from ORIGIN and Other Cardiovascular Trials.

Authors:  Markolf Hanefeld; Louis Monnier; Oliver Schnell; David Owens
Journal:  Diabetes Ther       Date:  2016-02-10       Impact factor: 2.945

8.  Associations of lipid profiles with insulin resistance and β cell function in adults with normal glucose tolerance and different categories of impaired glucose regulation.

Authors:  Shuang Zheng; Hua Xu; Huan Zhou; Xingxing Ren; Tingting Han; Yawen Chen; Huiying Qiu; Peihong Wu; Jun Zheng; Lihua Wang; Wei Liu; Yaomin Hu
Journal:  PLoS One       Date:  2017-02-15       Impact factor: 3.240

9.  Adipose Triglyceride Lipase Is a Key Lipase for the Mobilization of Lipid Droplets in Human β-Cells and Critical for the Maintenance of Syntaxin 1a Levels in β-Cells.

Authors:  Siming Liu; Joseph A Promes; Mikako Harata; Akansha Mishra; Samuel B Stephens; Eric B Taylor; Anthony J Burand; William I Sivitz; Brian D Fink; James A Ankrum; Yumi Imai
Journal:  Diabetes       Date:  2020-04-20       Impact factor: 9.461

10.  Association between Triglyceride-Glucose Index and Type 2 Diabetes Mellitus in the Japanese Population: A Secondary Analysis of a Retrospective Cohort Study.

Authors:  En-Qian Liu; Ya-Ping Weng; Ai-Ming Zhou; Chun-Lai Zeng
Journal:  Biomed Res Int       Date:  2020-12-11       Impact factor: 3.411

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.